phenotyping of patients with Advanced Chronic Liver Disease for better characterization of Cirrhosis Regression
Authors/Creators
- 1. Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
- 2. Institute of Clinical Chemistry, Bern University Hospital, University of Bern, Bern, Switzerland
Description
Regression of cirrhosis has been observed in patients with viral and non-viral etiologies of liver disease in whom the underlying cause of liver injury was effectively suppressed. However, the understanding of the factors contributing to reversibility of fibrosis and cirrhosis is limited. Our aim was to assess clinical factors, perform genotyping of known variants, and comprehensive metabolic phenotyping to characterize the regression of fibrosis in patients with compensated advanced chronic liver disease (cACLD).
In a case-control pilot study with 60 cACLD patients, we compared individuals exhibiting histological or clinical evidence of cACLD regression ("regressors") with those showing no improvement ("non-regressors") after a minimum of 24 months of successful therapy for the cause of liver disease.
A subgroup of 15 patients had paired frozen biopsies (before and after etiologic therapy) preserved and stored. RNA was extracted from those paired liver tissue (30 biopsies). RNA Sequencing data is saved in this repository
Files
Restricted
The record is publicly accessible, but files are restricted. Log in to check if you have access.
Request access
If you would like to request access to these files, please fill out the form below.
You need to satisfy these conditions in order for this request to be accepted:
researchers associated with a university
You are currently not logged in. Do you have an account? Log in here